Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · IEX Real-Time Price · USD
4.650
+0.060 (1.31%)
At close: Mar 28, 2024, 4:00 PM
4.500
-0.150 (-3.23%)
After-hours: Mar 28, 2024, 6:52 PM EDT
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $137.07 million as of March 28, 2024. Its market cap has increased by 88.29% in one year.
Market Cap
137.07M
Enterprise Value
40.75M
1-Year Change
88.29%
Ranking
Category
Stock Price
$4.65
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $137.07M, an increase of 142.18%. That is a compound annual growth rate of 10.97%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 138.50M | -2.12% |
Mar 26, 2024 | 141.50M | -4.33% |
Mar 25, 2024 | 147.90M | 0.89% |
Mar 22, 2024 | 146.60M | 4.27% |
Mar 21, 2024 | 140.60M | 5.08% |
Mar 20, 2024 | 133.80M | -17.41% |
Mar 19, 2024 | 162.00M | -2.47% |
Mar 18, 2024 | 166.10M | 1.84% |
Mar 15, 2024 | 163.10M | 7.73% |
Mar 14, 2024 | 151.40M | -10.84% |
Mar 13, 2024 | 169.80M | 2.04% |
Mar 12, 2024 | 166.40M | -4.20% |
Mar 11, 2024 | 173.70M | -9.11% |
Mar 8, 2024 | 191.10M | -0.31% |
Mar 7, 2024 | 191.70M | -0.47% |
Mar 6, 2024 | 192.60M | 1.26% |
Mar 5, 2024 | 190.20M | -0.47% |
Mar 4, 2024 | 191.10M | -6.64% |
Mar 1, 2024 | 204.70M | 11.01% |
Feb 29, 2024 | 184.40M | -0.22% |
Feb 28, 2024 | 184.80M | 3.53% |
Feb 27, 2024 | 178.50M | 0.34% |
Feb 26, 2024 | 177.90M | 4.04% |
Feb 23, 2024 | 171.00M | 2.58% |
Feb 22, 2024 | 166.70M | -2.69% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Electromed | 141.21M |
Zomedica | 141.11M |
FONAR | 140.68M |
Coya Therapeutics | 140.34M |
Biodesix | 139.60M |
TELA Bio | 139.15M |
Ocean Biomedical | 138.73M |
TruBridge | 138.69M |